Cronos Group expands in Europe with strong Q2 growth and CanAdelaar acquisition boost

Cronos Group Inc. is rapidly growing its international presence, especially in Europe, by capitalizing on cannabis legalization in Germany and acquiring CanAdelaar. The company reported a 58% year-over-year revenue increase to $53 million in Q2, supported by a favorable sales mix and stable operating costs. With nearly $800 million in cash and short-term investments against $56 million in liabilities, Cronos is well-positioned for share buybacks and future mergers and acquisitions. Analysts maintain a 'buy' rating, highlighting undervaluation and expected earnings growth from the acquisition.